CSL Limited is a global specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions.
CSL’s product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications.
Traded as: ASX: CSL
Industry: Biotechnology
Founded: 1916 (Federal government department), 1994 (privatised)
Headquarters: Parkville, Melbourne, Victoria, Australia[1]
Products: blood plasma, vaccines, antivenom, other laboratory and medical products
Divisions: CSL Behring; Seqirus
Website: www.csl.com.au